Escherichia coli K1's Capsule Is a Barrier to Bacteriophage T7
Open accessThe DOI matches its Crossref record.
Abstract
Escherichia coli strains that produce the K1 polysaccharide capsule have long been associated with pathogenesis. This capsule is believed to increase the cell's invasiveness, allowing the bacteria to avoid phagocytosis and inactivation by complement. It is also recognized as a receptor by some phages, such as K1F and K1-5, which have virion-associated enzymes that degrade the polysaccharide. In this report we show that expression of the K1 capsule in E. coli physically blocks infection by T7, a phage that recognizes lipopolysaccharide as the primary receptor. Enzymatic removal of the K1 antigen from the cell allows T7 to adsorb and replicate. This observation suggests that the capsule plays an important role as a defense against some phages that recognize structures beneath it and that the K1-specific phages evolved to counter this physical barrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
Bacteriophage Host Range and Bacterial Resistance
Hyman, P., & Abedon, S. T. (2010) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(10)70007-1 · Cited by 819
Revenge of the phages: defeating bacterial defences
Samson, J. E., Magadán, A. H., Sabri, M., & Moineau, S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3096 · Cited by 698
Origins and virulence mechanisms of uropathogenic Escherichia coli
Wiles, T. J., Kulesus, R. R., & Mulvey, M. A. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.03.007 · Cited by 606
Targeting mechanisms of tailed bacteriophages
Nobrega, F. L., Vlot, M., de Jonge, P. A., Dreesens, L. L., Beaumont, H. J. E., Lavigne, R., Dutilh, B. E., & Brouns, S. J. J. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0070-8 · Cited by 594
The highly diverse antiphage defence systems of bacteria
Georjon, H., & Bernheim, A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00934-x · Cited by 508
Bacterial defences: mechanisms, evolution and antimicrobial resistance
Smith, W. P. J., Wucher, B. R., Nadell, C. D., & Foster, K. R. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00877-3 · Cited by 385
Harper, D., Parracho, H., Walker, J., Sharp, R., Hughes, G., Werthén, M., Lehman, S., & Morales, S. (2014) · Antibiotics · doi:10.3390/antibiotics3030270 · Cited by 342
The next generation of bacteriophage therapy
Lu, T. K., & Koeris, M. S. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.028 · Cited by 312
Revisiting phage therapy: new applications for old resources
Nobrega, F. L., Costa, A. R., Kluskens, L. D., & Azeredo, J. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.01.006 · Cited by 310
Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules
Cress, B. F., Englaender, J. A., He, W., Kasper, D., Linhardt, R. J., & Koffas, M. A. G. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12056 · Cited by 282
“Furthermore, promising recent work has demonstrated the ability to engineer bacteriophages like T7 to degrade infectious biofilms (Azeredo & Sutherland, 2008) by expressing CPSspecific (Scholl et al., 2005) or EPS-specific (Lu & Collins, 2007) depolymerizing enzymes on their surface or tail spike, or by expressing the…”
Background(Ph)ighting Phages: How Bacteria Resist Their Parasites
Rostøl, J. T., & Marraffini, L. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.009 · Cited by 270
Intestinal phages interact with bacteria and are involved in human diseases
Shuwen, H., & Kefeng, D. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2113717 · Cited by 124
Genetic determinants of host tropism in Klebsiella phages
Beamud, B., García-González, N., Gómez-Ortega, M., González-Candelas, F., Domingo-Calap, P., & Sanjuan, R. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112048 · Cited by 113
Phosphonate production by marine microbes: exploring new sources and potential function
Acker, M., Hogle, S. L., Berube, P. M., Hackl, T., Coe, A., Stepanauskas, R., Chisholm, S. W., & Repeta, D. J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113386119 · Cited by 76
“Many marine microbes produce extracellular layers of polysaccharides to defend against predation (53) and surface-expressed structures protect against enzymatic attack, ultraviolet radiation, phages (54–56), and protozoan grazers (57–60).”
Capsules and their traits shape phage susceptibility and plasmid conjugation efficiency
Haudiquet, M., Le Bris, J., Nucci, A., Bonnin, R. A., Domingo-Calap, P., Rocha, E. P. C., & Rendueles, O. (2024) · Nature Communications · doi:10.1038/s41467-024-46147-5 · Cited by 72
Bacteriophage–host interaction: from splendid isolation into a messy reality
Brüssow, H. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.04.007 · Cited by 49
“coli prevents T7 phage from infection [30], a T7-like phage which expresses two different tail fibre proteins including an endosialidase specific for this capsular polysaccharide can infect the cell [31].”
BackgroundInteraction of phages, bacteria, and the human immune system: Evolutionary changes in phage therapy
Jariah, R. O. A., & Hakim, M. S. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2055 · Cited by 40
“coli produces K1 capsule, which hides the LPS receptor from phageT7 attachment.(23) In addition, bacteria may express a competitive inhibitor which binds to the phage receptors on the cell surface, thus make these receptors inaccessible to phages.”
BackgroundGoing for baroque at the Escherichia coli K1 cell surface
King, M. R., Steenbergen, S. M., & Vimr, E. R. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.03.006 · Cited by 20
Metadata
- Authors
- Scholl, D., Adhya, S., & Merril, C.
- Venue
- Applied and Environmental Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2005-08
- Volume
- 71
- Issue
- 8
- Pages
- 4872-4874
- ISSN
- 0099-2240 (ISSN-L)
- 1098-5336
- OpenAlex
- W2115069410
- Cited by
- 205
- References
- 0
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.